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Background.  Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV) incidence among human 
immunodeficiency virus (HIV)-positive men who have sex with men (MSM). International transmission could influence this pro-
cess. We classified HCV infections in HIV-positive MSM as either domestically or internationally acquired, and estimated how this 
classification changed over time.
Methods. HCV subtype 1a (the most frequent subtype among MSM) genomes from 99 persons enrolled in the Swiss HIV 
Cohort Study and diagnosed with replicating HCV infections, were sequenced. Sixty-six of these sequences were from MSM. We 
inferred maximum-likelihood phylogenetic trees and time trees containing a fragment of the NS5B region of these and 374 cir-
culating strains. We inferred transmission clusters from these trees and used the country composition of such clusters to attribute 
infections to domestic or international transmission.
Results. Of HCV transmissions, 50% to 80% were classified as domestic depending on the classification criterion. Between 2000 
and 2007, the fraction attributable to domestic transmission was 54% (range 0%–75%). It increased to 85% (range 67%–100%) be-
tween 2008 and 2016.
Conclusions. International and domestic transmission have played major roles in this epidemic. While international transmis-
sion persists, local transmission has established as the main source of infections.
Keywords. men who have sex with men; hepatitis C virus; HIV; direct-acting antivirals; transmission.
HIV-positive men who have sex with men (MSM) have become 
a main transmission group for hepatitis C virus (HCV) infection 
in Switzerland and other industrialized countries. Increased 
HCV transmission among human immunodeficiency virus 
(HIV)-positive MSM started to be reported in the early 2000s 
[1–4]. Molecular epidemiological analyses have demonstrated 
international networks of sexual transmission of HCV [5, 6]. 
The spread of HCV among HIV-positive MSM has continued 
ever since [4, 7–9].
Rapid scale-up of early direct-acting antiviral (DAA) therapy for 
HCV is ongoing in many European and non-European countries 
[10, 11] as reimbursement restrictions are progressively relieved. 
Projections from mathematical models for several Western coun-
tries [12–15] and early surveillance data from The Netherlands 
and Switzerland support the claim that DAA scale-up may abate 
the high incidence of HCV in HIV-positive MSM [15–18].
The relative magnitude of domestic versus international HCV 
transmission could be a key parameter for the success of isolated 
national treatment strategies. National microelimination and 
prevention programs can only be successful if a significant frac-
tion of infections is acquired domestically, while international 
coordination becomes more important with frequent interna-
tional transmission. Indirect genetic evidence from Switzerland 
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suggests an important role of domestic transmission [19]. 
Switzerland is ideally placed to study international transmission 
due to its small population size, the high proportion of MSM 
followed within the Swiss HIV Cohort Study (SHCS; www.shcs.
ch) [20], and its connections to international networks of sexual 
transmission [21, 22].
This study aimed to classify HCV infections in HIV-positive 
MSM in Switzerland as domestically or internationally ac-
quired, and to estimate how this classification changed over 
time. We did this by locating infections in transmission clus-
ters inferred from phylogenetic reconstructions and by timing 
transmission events.
METHODS
This study took place within the SHCS. The SHCS is a nation-
wide prospective cohort study that, since 1988, routinely collects 
clinical and epidemiological data from HIV-positive persons 
aged ≥ 18 years. The SHCS has been approved by the ethics com-
mittee of the participating centers and written informed consent 
was obtained from all participants. The prospectively collected 
data comprise behavioral and clinical information as well as 
laboratory measurements, including routine HCV antibody 
screening for incident infections and HCV RNA to detect rein-
fections. We estimate that more than 80% of all MSM diagnosed 
with HIV in Switzerland are followed within the cohort network 
[23, 24]. The prevalence of HCV in HIV-positive MSM in the 
SHCS was 4.8% in June 2016, and the fraction of infections with 
genotypes 1, 2, 3, and 4 were 72%, 1%, 5%, and 22%, respectively 
[16]. The molecular study reported here analysed subtype 1a, 
the most frequent one in our study population, accounting for 
60% of HCV infections. For genome sequencing, we included 
all MSM with HCV subtype 1a replicating infections who had 
plasma samples available for sequencing. We refer to these as 
Swiss MSM sequences.
To enable comparative analyses, we also sequenced addi-
tional cohort participants (other than MSM) with incident 
infections, also subject to availability of plasma samples from 
the SHCS biobank.
Sequencing of Hepatitis C Virus Infections
HCV RNA genome sequences were generated by amplification 
of almost full-length HCV RNA followed by massive parallel 
sequencing. Viral RNA was extracted from plasma stored in the 
SHCS biobank (www.shcs.ch) by an automated nucleic acid ex-
tractor (EasyMag, BioMerieux) [25] and Nucleospin RNA Virus 
Kit (Macherey-Nagel). RNA was then amplified by RT-PCR. 
A  MiSeq (Illumina) instrument was utilized for sequencing. 
Finally, a consensus sequence was generated for each HCV 
isolate by iterative sequence alignment against an HCV refer-
ence sequence with SmaltAlign (Institute of Medical Virology, 
University of Zürich). The HCV isolate H77 (GenBank ac-
cession number NC_004102) served as reference sequence. 
Our near full-length sequencing spanned nucleotides 62 to 
9376 of this reference. To allow comparison with international 
sequences we focused on the 436 base pair fragment coding for 
the C-terminal part of the NS5B region, because this segment 
is relatively abundant in public databases [26] and was the basis 
of previous studies on HCV transmission among MSM [5, 8, 9].
Maximum Likelihood Phylogenies
We compared 66 Swiss MSM sequences with a set of background 
sequences, which included 33 derived from incident infections in 
persons enrolled in the SHCS with HIV transmission risk other 
than MSM, 81 from chronic infections in persons enrolled in the 
SHCS, and 293 sequences retrieved from public databases [27] 
using the Basic Local Alignment Search Tool (BLAST) [28] to 
identify relevant background sequences by means of similarity 
criteria with respect to the sequences obtained for this study. We 
used RAxML [29] to infer maximum likelihood (ML) phyloge-
netic trees assuming a general time reversible with invariant sites 
(GTRI) model with gamma-distributed substitution rates with 4 
categories. One hundred replicates resulted in an estimation of the 
best tree and bootstrap supporting values for each bipartition.
Transmission Clusters
A subtree with a bootstrap support value ≥70% was defined as 
a transmission cluster (3 members or more) or a transmission 
pair (2 members). We only analyzed transmission clusters or 
pairs that included study sequences because only those are rele-
vant to the study question.
Likely Geographic Origin of Infections
We classified our study sequences as corresponding to trans-
missions likely to have occurred by contact with MSM living 
either in Switzerland or abroad, and termed them domestic or 
international transmissions, respectively. We classified a study 
sequence as corresponding to domestic transmission if it was 
located in a Swiss transmission cluster, and as corresponding to 
international transmission if it was located in an international 
transmission cluster. A transmission cluster was defined as Swiss 
when the fraction of its sequences that were Swiss equaled or 
exceeded a given threshold named Swiss dominance criterion. 
We studied Swiss dominance criteria ranging between 50% and 
90%. Likely geographic origin of sequences found to belong to 
more than 1 cluster was determined based on the most internal 
cluster or pair they belonged to.
International Linkages of the Swiss Epidemic
We defined and computed a measure of the strength of the 
linkage between the Swiss epidemic and those in other coun-
tries whose sequences could be included in our analyses. This 
measure consisted of assigning weights to each region according 
to its frequency of appearance in clusters containing Swiss MSM 
sequences. We defined the measure as follows: θg = 1Γ
∑
i
ρigγ
i 
where Γ =
∑
i
γi  is the total number of Swiss MSM sequences, 
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i indexes international clusters, γi is the number of Swiss MSM 
sequences in cluster i, g  indexes countries of origin other than 
Switzerland, and ρig  is the fraction of sequences in the interna-
tional cluster i with country of origin g .
Time Origin of Swiss Clusters
We estimated the origin of Swiss transmission clusters identified 
from the ML phylogenetic tree. These origins can be interpreted 
as proxies for introduction times of HCV into Switzerland, 
which resulted in domestic subepidemics.
For this purpose, we reinferred Swiss transmission clusters with 
5 or more members using BEAST [30], which resulted in time 
trees for each of these clusters. Our estimations of a  clusters’ ori-
gins corresponded to the heights of such time trees. BEAST anal-
yses utilized the general time-reversible substitution model with 
invariant sites (GTRI) with gamma-distributed rate variation (in 
accordance with the ML estimation depicted above) and an uncor-
related lognormal relaxed molecular clock model [31]. The Birth-
Death Skyline Serial model implemented in BEAST provided a 
surrogate HCV transmission model [32]. Supplementary Table 1 
provides further details on the parameterization of this analysis. 
The results reported here correspond to runs that reached Markov 
chain Monte Carlo chain lengths of 5 × 107. The minimum effective 
sample sizes across estimated parameters was >800.
Trends in Geographic Origin of HCV Infections
We identified time changes in the fraction of infections attribut-
able to domestic (versus international) transmission by timing 
the transmission events associated with our study sequences. 
As a proxy for transmission time, we used branching times 
involving our study sequences in a time tree. This time tree was 
constructed using BEAST by the same method as above and in-
cluded the same set of sequences as for the ML tree. For this 
estimation, we only considered branching times corresponding 
to nodes with posterior probabilities ≥70%.
BEAST analyses excluded sequences without available sam-
pling date.
Sensitivity Analysis
In order to test the robustness of the trends in geographic origin 
of HCV infections, we performed a sensitivity analysis on the 
time tree. This sensitivity analysis accounted for potential im-
balance of sampling rates (Swiss versus international sequences) 
over time. Such imbalance may arise from the fact that while the 
sampling of international sequences slowed down towards the 
end of the study period, the SHCS continued to perform HCV 
sequencing (see Supplementary Text 1).
RESULTS
Sequencing of Hepatitis C Virus Infections
Overall, by means of Illumina technology we obtained 99 HCV 
subtype 1a genomes from persons who were diagnosed with 
HCV infections between 1999 and 2016. Sixty-six were from 
63 MSM (3 reinfections) and constitute our study sequences, 
that is the Swiss MSM sequences. The Swiss MSM sequences 
accounted for 66% of infections with this genotype diagnosed 
in MSM enrolled in the SHCS during the study period. Table 1 
shows the characteristics of the MSM participants. Patients’ 
median age was 45 years (interquartile range, 41–51) and 75% 
(47/63) ever reported inconsistent condom use with occasional 
partners. Fifty-four percent (34/63) and 14% (9/63) reported 
the use of any or intravenous recreational drugs, respectively. 
Previous publications have described in detail HIV/HCV 
coinfected MSM enrolled in the SHCS [16, 17, 33]. Sampling 
dates of Swiss MSM sequences ranged between June 2002 and 
May 2016. The Swiss MSM sequences have been submitted to 
GenBank, accession numbers are MK314737 to MK314802.
Transmission Clusters
Ninety-one percent (60/66) of the Swiss MSM sequences were 
located within 14 MSM transmission clusters (7 nested, ie, embed-
ded in larger clusters) and 12 transmission pairs (8 nested) (Table 
2 and Figure 1). The mean within-cluster patristic distance was 
0.27% (range 0%–0.68%). This value fulfils commonly used cri-
teria for clustering (eg, 1%–10%), and therefore provides further 
support for the adopted cluster definition based on bootstrap 
values. Only 2 study sequences clustered or paired with sequences 
from men enrolled in the SHCS who reported intravenous drug 
use as the most likely mode of HIV transmission. Figure 1 displays 
all transmission clusters and pairs containing study sequences. 
Table 1. Characteristics of Men Who Have Sex With Men Included in 
the Study 
Characteristics Value
Number of patients 63
Age at sampling time, y, median (IQR) 45 (41–51)
ART ever started, n (%) 62 (94)
Drug use during follow-up, n (%)  
 Ever, all modes of administration 34 (54)
 Ever, intravenous 9 (14)
Sex with occasional partners, n (%)  
 Ever 63 (100)
Condom use with occasional partners, n (%)  
 Consistent 12 (19)
 Inconsistent 47 (75)
 Refuse to answer 0
 Missing 4 (6)
Ethnicity, n (%)  
 Caucasian 55 (87)
Education,a n (%)  
 Lower 6 (10)
 Intermediate 44 (70)
 High 11 (17)
 Unknown 2 (3)
Sixty-six sequences (including 3 reinfections) were obtained from 63 men who have sex 
with men. 
Abbreviation: ART, antiretroviral therapy.
aLower: mandatory school or lower; high: university.
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The median number of identifiable countries in clusters that were 
not Swiss-only clusters was 4 (range 2–9). Supplementary Figure 1 
shows the full phylogenetic tree.
The transmission clusters were identified as MSM clus-
ters based on cohort data in the case of Swiss sequences and 
by inspection of published reports in the case of international 
sequences. Table 2 depicts the clusters identified in this analysis.
Likely Geographic Origin of Infections
Fifty percent (30/60; Figure 1) of Swiss MSM sequences located 
in MSM transmission clusters or pairs were located in cluster C1, 
consisting predominantly of Swiss and German sequences. This 
cluster contained subtransmission clusters C4, C8, and tree trans-
mission pairs, all consisting only of Swiss sequences and including 
13 Swiss MSM sequences in total. Eighteen percent of study 
sequences (11/60) were located in cluster C2, consisting predomi-
nantly of Swiss and British sequences. The Swiss part of this cluster 
is a Swiss-only subtree, but the bootstrap support value for this 
subtree (60%) does not fulfil the criteria for a transmission cluster 
as defined for this study. Six sequences could not be linked to any 
transmission cluster. Overall, 50% (33/66) of Swiss MSM sequences 
were located in Swiss-only clusters or transmission pairs.
Likely geographic origin
Outside Europe
Other countries in Europe
Unknown
The Netherlands
The UK
Germany
Chronic from Switzerland
Swiss HIV + MSM
C13
C7
C5
C6
C12
C9
C8
C1
C4
C11
C14
C2
C3
C 10
Figure 1. Phylogenetic tree showing clusters that contained the study sequences (Swiss men who have sex with men [MSM] sequences). Clusters were defined as mono-
phyletic trees with ≥70% bootstrap support value. The full tree (from which this one is derived, Supplementary Figure 1) was computed using RAxML with 100 replicates and 
a general time reversible model with invariant sites and gamma-distributed substitution rates.
Table 2. Description of Transmission Clusters in Figure 1 and Estimated Origin
Primary Nested Size Study Sequences (n) Swissness, % Estimated Time Origin
C1 52 30 65 …
 C4 6 4 100 Jun 2007
 C8 3 3 100 …
C2  33 11 33 …
 C3 27 11 41 …
C5  19 4 21 …
 C6 18 4 22 …
 C9 17 3 18 …
 C12 3 1 33 …
C7  5 4 80 Nov 2000
 C10 3 3 100 …
C11  6 3 100 Oct 1999
C13  11 1 9 …
C14  36 1 14 …
The order of cluster indices reflects the number of studied sequences located in the respective cluster; Swissness refers to the fraction of sequences of Swiss origin in the cluster. The table 
reports time of origin for clusters with 5 or more members and Swissness equal or larger than 80%. Time trees are shown in Supplementary Figure 2.
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Figure 2A shows the fractions of study sequences classified 
as domestic, international, and unknown transmission for a 
range of Swiss dominance criteria (minimum percentage of 
sequences in the clusters that are required to classify a cluster 
as Swiss). When this criterion was set to 50% or 60%, 80% and 
79% of sequences were classified as domestic transmission, re-
spectively. When the criterion was raised to 90%, half of the 
sequences were classified as domestic transmission.
International Linkages of the Swiss Epidemic
Figure 2B shows a measure of the strength of the linkage be-
tween the HCV epidemic in Switzerland and those in other 
countries as suggested by the ML phylogenetic tree. This 
measure suggests that the Swiss epidemic is closely linked to 
those in the UK, The Netherlands, and Germany.
Time Origin of Swiss Clusters
We next investigated the time origin of the best-supported 
Swiss dominated clusters. For these estimates, monophyletic 
trees containing 5 or more members and fulfilling a Swiss dom-
inance criterion of 80% (Table 2) defined a best-supported Swiss 
cluster. Phylodynamic reinference of these clusters estimated 
that their origins ranged between (median) October 1999 and 
June 2007 (Table 2 and Supplementary Figure 2).
Trends in Geographic Origin of HCV Infections
The time tree constructed including all sequences with avail-
able sampling dates suggests that until 2004 most transmis-
sions occurred by contact with MSM not living in Switzerland 
(Figure 3). Of note, none of MSM whose transmissions were 
estimated to have occurred before 2002 ever reported drug in-
jection. Neither did they cluster with Swiss sequences from per-
sons reporting drug injection.
Between 2000 and 2007, the fraction attributable to domestic 
transmission was 54% (range 0%–75%). It increased to 85% (range 
67%–100%) from 2008 to the end of the study period (Figure 3).
Sensitivity Analysis
The sensitivity analysis (Supplementary Figure 3) supports the 
observation, derived from Figure 3, that the contribution of do-
mestic transmission increased over time. Supplementary Figure 
3 suggests that changing sampling rates do not explain the 
increasing trend in domestic transmission displayed in Figure 
3. The simulated fraction attributable to domestic transmission 
(for 80% dominance criterion) increased from 25% (95% confi-
dence interval [CI], 11%–25%) between 2000 and 2007 to 82% 
(CI, 51%–85%) between 2008 and 2016 (versus 54% and 85% 
for the same time periods in the main analysis). These results 
suggest that our main findings were robust to variations in sam-
pling density.
DISCUSSION
This molecular epidemiology study suggests that both Swiss 
domestic and international HCV transmission contribute sub-
stantially to the HCV epidemic among HIV-positive MSM in 
Switzerland. The relative contribution of international transmis-
sion declined with time and gave way to domestic transmission 
as the major source of infections. We found no significant trace 
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Figure 2. Likely geographic origin of infection (A) and international linkages of the Swiss men who have sex with men (MSM) sequences (B). This classification was derived 
from the clusters identified in the maximum likelihood phylogenetic tree. Swiss dominance criteria was defined as minimum percentage of sequences in the clusters that are 
Swiss necessary to classify a cluster as Swiss. Abbreviation: HCV, hepatitis C virus.
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of transmission bridging from persons who became infected 
with HIV through drug injection and MSM within Switzerland, 
suggesting that the HCV epidemics in these 2 HIV transmis-
sion groups are likely disconnected. This is in line with a former 
phylogenetic study of HIV transmission in Switzerland were 
only 2% of HIV sequences from persons who inject drugs clus-
tered with those from MSM [22]. Due to lack of behavioral data 
on concurrence of sexual practices associated with HCV trans-
mission and the use of intravenous drugs [34, 35], our study 
could not assess frequencies of HCV transmission routes (ie, 
traumatic sex versus intravenous drug use).
Our analyses suggest that the initial cases of sexually trans-
mitted HCV in MSM in Switzerland are mainly attributable 
to international transmissions among MSM, and not to spill-
overs between persons who inject drugs and MSM within 
Switzerland. Swiss-domestic HCV transmission among MSM 
has grown over time. This implies that intensive test-and-
treat interventions at the national level are likely to succeed. 
This notion is supported by data from Switzerland, where the 
Swiss HCVree Trial, a test-treat-and-counsel study [14, 17–18] 
has been followed by a decline in the number of cases of acute 
HCV infections among MSM in the SHCS. Importantly, early 
data from the Netherlands also indicate declines in incident 
cases in this population after introduction of universal access 
to DAA therapy [10]. Our finding of persistent international 
transmissions may imply that coordinated HCV treatment 
scale-up in different countries could amplify the decrease in 
HCV transmissions.
The estimated time origins of Swiss transmission clusters 
can be interpreted as illustrations of critical time points when 
treatment and/or behavioral interventions could have had pre-
vented new transmission chains. We estimated the origins of 
Swiss clusters to be between 1999 and 2007, which overlaps 
with a sharp rise in HCV incidence among HIV-positive MSM 
in Switzerland [2, 33]. This may have been due, at least partially, 
to such introduced cases spreading in Switzerland.
Limitations
This analysis relied on public databases to obtain background 
international sequences. While a large number of these were 
included, the fact that European countries may be unevenly 
represented in GenBank, is a limitation of this study. Our esti-
mations on linkages of the Swiss epidemic to specific countries 
were therefore likely biased. The segment of the HCV genome 
that we chose for these analyses was the one that resulted in 
the most suitable set of background sequences, in particular 
because it has been the basis of other phylogenetic analyses 
across Europe [5, 36]. However, countries such as France and 
Italy were likely under-represented in our analyses (only 8 and 
3 sequences, respectively, were included). More even sampling 
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Figure 3. Time trends in the fraction of hepatitis C virus (HCV) infections attributable to domestic and international transmission. This classification assumed an 80% 
dominance criterion and was derived from the time tree inferred using BEAST 2.0. Branching times involving our study sequences (Swiss men who have sex with men [MSM] 
sequences) served as proxy for transmission times.
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rates across geographic regions, as well as increased sequenc-
ing of longer regions of the HCV genome, should improve esti-
mates of transmission patterns in the future [37].
The fact that the number of international HCV sequences 
available from public databases declined towards the end of the 
study period is also a potential limitation of this study. It could 
potentially have led to overestimations of the contribution of 
domestic transmission towards the end of the study period. 
However, the contribution of domestic transmission started 
to increase early on, before this disparity could have had any 
effect. Moreover, the estimated time trend in domestic versus 
international transmission held true when subjected to a sen-
sitivity analysis that assumed a set of hypothetical international 
sequences iteratively attaching to the transmission clusters, 
which deliberately decreased the likelihood of domestic trans-
mission. Finally, potential under-reporting of intravenous drug 
injection may have prevented us from recognizing more trans-
mission bridges between MSM and persons who inject drugs.
Implications of Findings
To our knowledge, this is the first study to quantify the con-
tribution over time of international transmission to a national 
HCV epidemic in MSM. We did this by combining phylogenetic 
and phylodynamic analyses of a representative sample of HCV 
genome sequences from infections observed in Switzerland.
Previous studies have demonstrated the emergence of epidem-
ics of HCV transmitted through sexual practices and depicted its 
separation from transmission networks formed by persons who 
inject drugs [5, 36]. These molecular epidemiological studies re-
vealed international networks of HCV transmission among HIV-
positive MSM. Our study evidences high levels and increases of 
domestic transmission within Switzerland. It also indicates that 
the contribution of international HCV transmission networks 
persists although its importance declined over time.
Previous modelling studies and empiric data indicate that 
DAA scale-up has the potential to curb the HCV epidemic 
among HIV-positive MSM [12–15]. Our results suggest that for 
a successful treatment-as-prevention approach and a correct in-
terpretation of its effects, international transmission should be 
considered, and that targeted joint European scale-up schemes 
may increase the efficiency of such interventions.
Regularly updated HCV phylogenies for Europe could help 
monitor the impact of national DAA scale-up programs, and 
they would allow measurement of the effect of treatment-as-pre-
vention on large-scale transmission networks. This requires in-
ternational coordination to sequence the same or overlapping 
regions of the HCV genome.
CONCLUSION
This molecular epidemiological study suggests that both inter-
national and local transmission have played major roles in the 
Swiss epidemic of hepatitis C among HIV-positive MSM, and 
that, while international transmission persists, Swiss domestic 
transmission has gained importance over time.
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